IBDEI2M3 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1053,0)
 ;;=PARAPHILIC DISORDERS^25^90
 ;;^UTILITY(U,$J,358.4,1054,0)
 ;;=PERSONALITY DISORDERS^27^90
 ;;^UTILITY(U,$J,358.4,1055,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^7^90
 ;;^UTILITY(U,$J,358.4,1056,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^28^90
 ;;^UTILITY(U,$J,358.4,1057,0)
 ;;=RELATIONAL PROBLEMS^29^90
 ;;^UTILITY(U,$J,358.4,1058,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^30^90
 ;;^UTILITY(U,$J,358.4,1059,0)
 ;;=SEXUAL DYSFUNCTION^31^90
 ;;^UTILITY(U,$J,358.4,1060,0)
 ;;=SLEEP DISORDERS^32^90
 ;;^UTILITY(U,$J,358.4,1061,0)
 ;;=SUBSTANCE ABUSE-ALCOHOL^35^90
 ;;^UTILITY(U,$J,358.4,1062,0)
 ;;=SUBSTANCE ABUSE-AMPHETAMINE^36^90
 ;;^UTILITY(U,$J,358.4,1063,0)
 ;;=SUBSTANCE ABUSE-CANNABIS^38^90
 ;;^UTILITY(U,$J,358.4,1064,0)
 ;;=SUBSTANCE ABUSE-HALLUCINOGEN^40^90
 ;;^UTILITY(U,$J,358.4,1065,0)
 ;;=SUBSTANCE ABUSE-OPIOID^42^90
 ;;^UTILITY(U,$J,358.4,1066,0)
 ;;=SUBSTANCE ABUSE-PSYCHOACTIVE DRUGS^43^90
 ;;^UTILITY(U,$J,358.4,1067,0)
 ;;=SUBSTANCE ABUSE-SEDATIVE/HYPNOTIC^44^90
 ;;^UTILITY(U,$J,358.4,1068,0)
 ;;=SUBSTANCE ABUSE-TOBACCO^45^90
 ;;^UTILITY(U,$J,358.4,1069,0)
 ;;=SUBSTANCE ABUSE-COCAINE^39^90
 ;;^UTILITY(U,$J,358.4,1070,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^46^90
 ;;^UTILITY(U,$J,358.4,1071,0)
 ;;=SUBSTANCE ABUSE-INHALANT^41^90
 ;;^UTILITY(U,$J,358.4,1072,0)
 ;;=INTELLECTUAL DISABILITIES^19^90
 ;;^UTILITY(U,$J,358.4,1073,0)
 ;;=CLINICAL RESEARCH PROGRAM^5^90
 ;;^UTILITY(U,$J,358.4,1074,0)
 ;;=SOMATOFORM DISORDERS^34^90
 ;;^UTILITY(U,$J,358.4,1075,0)
 ;;=DISRUPTIVE,IMPULSE-CONTROL DISORDERS^11^90
 ;;^UTILITY(U,$J,358.4,1076,0)
 ;;=ELIMINATION DISORDERS^15^90
 ;;^UTILITY(U,$J,358.4,1077,0)
 ;;=GAMBLING DISORDER^16^90
 ;;^UTILITY(U,$J,358.4,1078,0)
 ;;=OTHER MENTAL DISORDERS^24^90
 ;;^UTILITY(U,$J,358.4,1079,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^21^90
 ;;^UTILITY(U,$J,358.4,1080,0)
 ;;=SUBSTANCE ABUSE-CAFFEINE^37^90
 ;;^UTILITY(U,$J,358.4,1081,0)
 ;;=GROUP PSYCHOTHERAPY/INTERVENTION^2^91
 ;;^UTILITY(U,$J,358.4,1082,0)
 ;;=OTHER^8^91
 ;;^UTILITY(U,$J,358.4,1083,0)
 ;;=TEAM CONFERENCE^7^91
 ;;^UTILITY(U,$J,358.4,1084,0)
 ;;=SUBSTANCE ABUSE^6^91
 ;;^UTILITY(U,$J,358.4,1085,0)
 ;;=CASE MANAGEMENT^1^91
 ;;^UTILITY(U,$J,358.4,1086,0)
 ;;=INJECTION ADMINISTRATION^4^91
 ;;^UTILITY(U,$J,358.4,1087,0)
 ;;=INJECTIONS/MEDICATIONS^5^91
 ;;^UTILITY(U,$J,358.4,1088,0)
 ;;=IN-HOME BEHAVIOR/HEALTH ASSESSMENT^3^91
 ;;^UTILITY(U,$J,358.4,1089,0)
 ;;=ESTABLISHED PATIENT^1^92
 ;;^UTILITY(U,$J,358.4,1090,0)
 ;;=ABUSE AND NEGLECT^1^93
 ;;^UTILITY(U,$J,358.4,1091,0)
 ;;=ANXIETY DISORDERS^3^93
 ;;^UTILITY(U,$J,358.4,1092,0)
 ;;=BIPOLAR DISORDERS^4^93
 ;;^UTILITY(U,$J,358.4,1093,0)
 ;;=DELIRIUM^8^93
 ;;^UTILITY(U,$J,358.4,1094,0)
 ;;=DEMENTIA/NEUROCOGNITIVE DISORDERS^9^93
 ;;^UTILITY(U,$J,358.4,1095,0)
 ;;=DEPRESSIVE DISORDERS^10^93
 ;;^UTILITY(U,$J,358.4,1096,0)
 ;;=DISSOCIATIVE DISORDERS ^12^93
 ;;^UTILITY(U,$J,358.4,1097,0)
 ;;=EATING & FEEDING DISORDERS^13^93
 ;;^UTILITY(U,$J,358.4,1098,0)
 ;;=EDUCATIONAL/OCCUPATIONAL PROBLEMS^14^93
 ;;^UTILITY(U,$J,358.4,1099,0)
 ;;=GENDER DYSPHORIA^17^93
 ;;^UTILITY(U,$J,358.4,1100,0)
 ;;=HOUSING/ECONOMIC PROBLEMS^18^93
 ;;^UTILITY(U,$J,358.4,1101,0)
 ;;=MEDICATION-INDUCED MOVEMENT DISORDERS^20^93
 ;;^UTILITY(U,$J,358.4,1102,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^22^93
 ;;^UTILITY(U,$J,358.4,1103,0)
 ;;=ORGANIC DISORDERS^23^93
 ;;^UTILITY(U,$J,358.4,1104,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^26^93
 ;;^UTILITY(U,$J,358.4,1105,0)
 ;;=ADHD^2^93
 ;;^UTILITY(U,$J,358.4,1106,0)
 ;;=COUNSELING/MED ADVICE^6^93
 ;;^UTILITY(U,$J,358.4,1107,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^33^93
